Company Profiles

driven by the PitchBook Platform

Accera

Description

Operator of a clinical development company intended to heal central nervous system diseases. The company's focus lies in pioneering novel therapeutic approaches to treat neurodegenerative diseases, including Alzheimer's disease, where metabolic dysfunction is a pathophysiological hallmark of the disease.

2001

Founded

PRIVATE

Status

11-50

Employees

Series E

Latest Deal Type

$84.1M

Latest Deal Amount

$170M

Total Amount Raised

Description

Operator of a clinical development company intended to heal central nervous system diseases. The company's focus lies in pioneering novel therapeutic approaches to treat neurodegenerative diseases, including Alzheimer's disease, where metabolic dysfunction is a pathophysiological hallmark of the disease.

Website:

www.accerapharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Discovery Tools (Healthcare)
Drug Discovery

Primary Office

3005 Center Green Drive Suite 205 Boulder, CO 80301United States +1 (303) 999-3700
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Accera's full profile, request a free trial.

Accera Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Accera Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Accera Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Innova Capital (Brazil)Venture CapitalMinority000 0000000 0000
Inventages Venture CapitalVenture CapitalMinority000 0000000 0000
Nestlé Health ScienceCorporationMinority000 0000000 0000
Posco BioVenturesVenture CapitalMinority000 0000000 0000
Innova Capital (Brazil) Venture Capital
Inventages Venture Capital Venture Capital
Nestlé Health Science Corporation
Posco BioVentures Venture Capital

Accera Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Charles StaceyPresident & Chief Executive Officer
C. Evan BallantyneChief Financial Officer
Jerris KnaischVice President, Finance
Ernest Wong Ph.DVice President of Corporate Development
Bruce Morimoto Ph.DVice President of Drug Developemnt
Charles Stacey President & Chief Executive Officer
C. Evan Ballantyne Chief Financial Officer
Jerris Knaisch Vice President, Finance
Ernest Wong Ph.D Vice President of Corporate Development
Bruce Morimoto Ph.D Vice President of Drug Developemnt

Accera Board Members (4)

NameRepresentingRoleSinceContact
Info
Claude Nash Ph.DSelfChairman000 0000
Grégory BeharNestlé Health ScienceChief Executive Officer & Board Member000 0000
Sven Thormahlen Ph.DSelfBoard Member000 0000
Wolfgang ReichenbergerInventages Venture CapitalPartner000 0000
Claude Nash Ph.D Chairman Self
Grégory Behar Chief Executive Officer & Board Member Nestlé Health Science
Sven Thormahlen Ph.D Board Member Self
Wolfgang Reichenberger Partner Inventages Venture Capital
Request full access to PitchBook